- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
ACP 2023 Guideline on Pharmacologic Treatment of Osteoporosis: A Guideline Topline
The American College of Physicians has updated its guideline from 2017 for pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
Key recommendations include use of bisphosphonates as initial treatment of postmenopausal women and men diagnosed with primary osteoporosis and prescribing of the RANK (receptor activator of nuclear factor-κB) ligand inhibitor, denosumab, as second-line in those with contraindications or previous adverse effects to bisphosphonates.
Whether or not to initiate pharmacologic treatment for osteopenia in women aged 65 years is a decision to be made on a case-by-case basis, the guideline recommends, given uncertainty that it would reduce risk of fractures.
The following slideshow summary for primary care is a topline look at the essential recommendations and rationale for each.
Reference: Quaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, et al. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Intern Med. 2023;176:224-238. doi:10.7326/M22-1034
Primary Viewpoints Episode 7: Antidepressants for Back Pain, Osteoarthritis Pain
February 25th 2021Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.
Podcast: Arthritis, Anxiety, and Depression: Managing a Common Comorbidity
May 14th 2012Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.
